News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Newsfile Corp
NEWS
IN THE PRESS
Press Releases
Envoy Medical Reports on Second Quarter 2025 Results
July 31, 2025
·
16 min read
Press Releases
PharmaDrug Inc.: Correction to News Release Dated July 30, 2025
July 30, 2025
·
14 min read
Press Releases
BioMark Diagnostics Highlights Fiscal Year 2025 Achievements and Sets Bold Strategic Milestones for 2025 - 2026
July 30, 2025
·
5 min read
Press Releases
PharmaDrug Signs LOI to Acquire Equity Interest in Canurta Inc.
July 30, 2025
·
13 min read
Press Releases
Sharp Therapeutics Corp. Engages Rho Inc. to Help Advance Compounds into Clinical Trials for Gaucher Disease
July 30, 2025
·
5 min read
Press Releases
Britannia Life Sciences Inc. Announces $10 Million Debenture Offering to Provide Investor Access to Asset-Backed Loan Portfolio
July 28, 2025
·
5 min read
Press Releases
Theralase(R) Closes Non-Brokered Private Placement
July 28, 2025
·
6 min read
Press Releases
InMed to Present INM-901 Data at Alzheimer’s Association International Conference (AAIC) 2025
July 28, 2025
·
5 min read
Press Releases
Adaptimmune Announces Entry into Definitive Agreement for Sale of TECELRA, lete-cel, afami-cel and uza-cel Cell Therapies to US WorldMeds
July 28, 2025
·
6 min read
Press Releases
Phio Pharmaceuticals Announces Exercise of Warrants for Approximately $2.5 Million Gross Proceeds
July 25, 2025
·
6 min read
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us